Berenberg Bank reaffirmed their buy rating on shares of Johnson Matthey (LON:JMAT) in a research report sent to investors on Tuesday, ThisIsMoney.Co.Uk reports.
Other equities analysts have also recently issued research reports about the company. UBS Group reiterated a sell rating on shares of Johnson Matthey in a research report on Thursday, July 18th. Liberum Capital reiterated a buy rating on shares of Johnson Matthey in a research report on Wednesday, July 17th. Credit Suisse Group reiterated an outperform rating on shares of Johnson Matthey in a research report on Friday, May 31st. HSBC upped their price target on Johnson Matthey from GBX 3,650 ($47.69) to GBX 3,750 ($49.00) and gave the stock a buy rating in a report on Wednesday, June 5th. Finally, Deutsche Bank restated a buy rating on shares of Johnson Matthey in a report on Thursday, July 18th. One research analyst has rated the stock with a sell rating and six have assigned a buy rating to the stock. The company has an average rating of Buy and a consensus target price of GBX 3,738.33 ($48.85).
LON JMAT opened at GBX 2,806 ($36.67) on Tuesday. The company has a current ratio of 1.64, a quick ratio of 0.95 and a debt-to-equity ratio of 50.40. The business’s 50 day moving average is GBX 3,081.28 and its two-hundred day moving average is GBX 3,166.88. Johnson Matthey has a 12-month low of GBX 2,574 ($33.63) and a 12-month high of GBX 3,692 ($48.24). The stock has a market capitalization of $5.43 billion and a price-to-earnings ratio of 13.08.
In other news, insider Robert MacLeod purchased 12 shares of the stock in a transaction that occurred on Wednesday, July 17th. The shares were acquired at an average price of GBX 3,225 ($42.14) per share, for a total transaction of £387 ($505.68). In the last 90 days, insiders purchased 36 shares of company stock worth $110,448.
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.
Featured Story: What are retained earnings?
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.